Document is current
Any future updates will be listed below
-
Authors
Mori, Hideki
Suzuki, Hidekazu https://orcid.org/0000-0002-8994-6163
- License Information
-
More Information
Article History
Received: 27 March 2026
Accepted: 13 April 2026
First Online: 19 May 2026
Declarations
:
: Hidekazu Suzuki has received research funding from Tohso Co., Ltd., and honoraria from Astellas Pharmaceutical Company, Otsuka Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd. Hideki Mori declares no conflicts of interest.
